earnings
confidence high
sentiment neutral
materiality 0.70
Amarin reports preliminary 2021 revenue ~$580M, appoints Per Wold-Olsen to board
AMARIN CORP PLCUK
2021-FY EPS reported
$0.02
revenue$583,187,000
- Full-year 2021 net revenue ~$580M; Q4 revenue ~$140M, stable vs Q3.
- Ended 2021 with ~$490M cash/investments and no debt.
- Plans to develop fixed-dose combination of VASCEPA and a statin.
- Per Wold-Olsen appointed to Board effective Jan 10, 2022; receives $540K in equity awards.
- 2022 revenue guidance not provided due to COVID/generic uncertainty; US ops expect positive contribution margin.